Recombinant Proteins of Therapeutic Interest Expressed by Lymphoid Cell Lines Derived from Transgeni

Author:  ["Andrea Pavirani","Tim Skern","Marianne Le Meur","Yves Lutz","Richard Lathe","Ronald G. Crystal","Jean-Paul Fuchs","Pierre Gerlinger","Michael Courtney"]

Publication:  Bio/Technology

CITE.CC academic search helps you expand the influence of your papers.

Tags:  general   Biotechnology   Biomedicine   general   Agriculture   BiomedicalEngi   Biological

Abstract

As a new approach to produce human proteins of therapeutic interest we have derived lymphoid cell lines expressing such proteins from transgenic mice, either by generating trans-hybridomas by cell fusion in vitro or by onc gene-mediated immortalisation in vivo of transgenic lymphocytes. The latter procedure could be applied to different cell types for the expression of proteins that require tissue-specific modifications.

Cite this article

Pavirani, A., Skern, T., Meur, M. et al. Recombinant Proteins of Therapeutic Interest Expressed by Lymphoid Cell Lines Derived from Transgenic Mice. Nat Biotechnol 7, 1049–1054 (1989). https://doi.org/10.1038/nbt1089-1049

View full text

>> Full Text:   Recombinant Proteins of Therapeutic Interest Expressed by Lymphoid Cell Lines Derived from Transgeni

Plantlet Regeneration from Embryogenic Protoplasts of White Spruce (Picea Glauca)

Expression of Human β1 and β2 Adrenergic Receptors in E. Coli As a New Tool for Ligand Screening